Send us Feedback

Pimco Municipal Income Fund II (PML)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
PIMCO Municipal Income Fund II Reports Results for the Fiscal Quarter and Six Months Ended November 30, 2011
Business Wire  Jan 30  Comment 
PIMCO Municipal Income Fund II (the "Fund") (NYSE:PML), a closed-end management investment company which seeks to provide current income exempt from federal income tax, today announced its results for the fiscal quarter and six months ended November
Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
Benzinga  Jan 20  Comment 
Quest Diagnostics (NYSE: DGX) today announced that the U.S. Food and Drug Administration has granted a de novo classification petition to its STRATIFY JCV™ Antibody ELISA testing service. STRATIFY JCV is the first blood test to be FDA market...
FDA OKs PML Risk Test for Patients on Tysabri
MedPage Today  Jan 20  Comment 
FRA Grants Quest Diagnostics (DGX) First Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in MS Patients
StreetInsider.com  Jan 20  Comment 
More PML Cases Turn Up With Adcetris
MedPage Today  Jan 13  Comment 
(MedPage Today) -- Two new cases of a life-threatening brain inflammation have been seen in patients treated with the lymphoma drug brentuximab vedotin (Adcetris), the FDA said.
Seattle Genetics (SGEN) Updates on Prescribing Info for ADCETRIS; Highlights PML Warning
StreetInsider.com  Jan 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Seattle+Genetics+%28SGEN%29+Updates+on+Prescribing+Info+for+ADCETRIS%3B+Highlights+PML+Warning/7080428.html for the full story.
Phoenix Mills all set to reap benefits of revised rentals
The Economic Times  Jul 5  Comment 
While most other realty stocks have failed to gain during the period under review, PML's stock has earned 6%.
CMSC: Age, Time to Diagnosis Predict PML Survival (CME/CE)
MedPage Today  Jun 6  Comment 
MONTREAL (MedPage Today) -- Younger age, faster diagnosis, and undergoing treatment in Europe were among the factors associated with greater likelihood of survival in cases of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis...
Survival in MS-based PML Improves, But Disability Still High (CME/CE)
MedPage Today  May 22  Comment 
(MedPage Today) -- Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.
FDA: Tysabri risks greatest during year 3
FiercePharma  Apr 25  Comment 
The FDA has updated its warning on Biogen Idec's multiple sclerosis drug Tysabri. According to the agency, the risk of a potentially fatal brain infection appears to be greatest during the third year of treatment. Since Tysabri was reintroduced...
AAN: Case Report Links Cladribine to PML (CME/CE)
MedPage Today  Apr 13  Comment 
HONOLULU (MedPage Today) -- A patient treated with cladribine for hairy cell leukemia went on to develop progressive multifocal leukoencephalopathy, suggesting that the drug may pose a similar risk when used in multiple sclerosis, researchers...




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Pimco_Municipal_Income_Fund_II_(PML)"
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki